Positive rate and quantification of amyloid pathology with [18F]florbetapir in the urban Chinese population-Reference-Cited by-同舟云学术

Positive rate and quantification of amyloid pathology with [18F]florbetapir in the urban Chinese population

Published:2023-10-27 Issue: Volume: Page:
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

He Kun,Li Binyin,Huang Lin,Zhao Jun,Hua Fengchun,Wang Tao,Li Junpeng,Wang Jie,Huang Qi,Chen Keliang,Xu Shasha,Ren Shuhua,Cai Huawei,Jiang Donglang,Hu Jingchao,Han Xingmin,Guan Yihui,Chen Kewei,Guo Qihao,Xie Fang^ORCID

Funder

National Science Foundation of China

National Key R&D Program of China

Shanghai Sailing Program

startup fund of Huashan Hospital

Shanghai Municipal Key Clinical Specialty

Shanghai Municipal Science and Technology Major Project

Shanghai Rising-Star Program

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-023-10366-z.pdf

Reference64 articles.

1. Jia L, Du Y, Chu L et al (2020) Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5:e661–e671

2. Kern S, Zetterberg H, Kern J et al (2018) Prevalence of preclinical Alzheimer disease: comparison of current classification systems. Neurology 90:e1682–e1691

3. Ding D, Zhao Q, Guo Q et al (2015) Prevalence of mild cognitive impairment in an urban community in China: a cross-sectional analysis of the Shanghai Aging Study. Alzheimers Dement 11:300-309.e302

4. Jia J, Zhou A, Wei C et al (2014) The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement 10:439–447

5. Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG (2019) Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 26:33